Drug Profile
Malaria vaccine - Artificial Cell Technologies
Alternative Names: ACT-1239; Synthetic nanocapsule malaria vaccine - Artificial Cell Technologies (ACT)Latest Information Update: 28 Nov 2023
Price :
$50
*
At a glance
- Originator Artificial Cell Technologies
- Class Parasitic vaccines; Peptide vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 28 Nov 2023 No recent reports of development identified for phase-I development in Malaria(Prevention, In volunteers) in Australia
- 30 Jan 2023 Artificial Cell Technologies plans a phase Ib CHMI trial for Malaria (Prevention)
- 11 Nov 2021 Phase-I development is ongoing for Malaria vaccine in Australia